TY - JOUR
T1 - Publisher Correction
T2 - Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)
AU - the DESTINY-Breast12 study group
AU - Harbeck, Nadia
AU - Ciruelos, Eva
AU - Jerusalem, Guy
AU - Müller, Volkmar
AU - Niikura, Naoki
AU - Viale, Giuseppe
AU - Bartsch, Rupert
AU - Kurzeder, Christian
AU - Higgins, Michaela J.
AU - Connolly, Roisin M.
AU - Baron-Hay, Sally
AU - Gión, María
AU - Guarneri, Valentina
AU - Bianchini, Giampaolo
AU - Wildiers, Hans
AU - Escrivá-de-Romaní, Santiago
AU - Prahladan, Manoj
AU - Bridge, Helen
AU - Kuptsova-Clarkson, Nataliya
AU - Scotto, Nana
AU - Verma, Sunil
AU - Lin, Nancy U.
AU - Anders, Carey
AU - Hall, Peter
AU - Zaman, Khalil
AU - Aebi, Stefan
AU - Rossi, Lorenzo
AU - Klint, Leif
AU - Killander, Fredrika
AU - Schiza, Aglaia
AU - del Prado, Purificación Martínez
AU - González, Carmen Hinojo
AU - Flores, Encarnación González
AU - Sanchez, César Rodríguez
AU - López, Rafael López
AU - Castán, Javier Cortés
AU - Borrego, Manuel Ruiz
AU - Marti, Maria Pilar Lopez
AU - Gregori, Joaquin Gavilá
AU - Manich, Cristina Saura
AU - Losada, María Jesús Vidal
AU - Sousa, Ana Rita
AU - Cardoso, Fatima
AU - Simões, Joana
AU - Duchnowska, Renata
AU - Jassem, Jacek
AU - Radecka, Barbara
AU - Nowecki, Zbigniew
AU - Wysocki, Piotr
AU - Sætersdal, Anna
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03261-7, published online 13 September 2024. In the version of this article initially published, members of the DESTINY-Breast12 study group were not included by the journal in the full text. In Table 1, under the “Prior CNS therapies n (%)” section, seven rows have been added, in addition to the original CNS radiotherapy, WBRT and SRS rows. In Table 1 and in the Results: Patients section, “intracranial therapy” has been amended to “CNS radiotherapy,” while the text “the type of intracranial radiotherapy was not always recorded by investigators, and only WBRT and SRS intracranial radiotherapy were reported” has been removed. All changes appear in the HTML and PDF versions of the article.
AB - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03261-7, published online 13 September 2024. In the version of this article initially published, members of the DESTINY-Breast12 study group were not included by the journal in the full text. In Table 1, under the “Prior CNS therapies n (%)” section, seven rows have been added, in addition to the original CNS radiotherapy, WBRT and SRS rows. In Table 1 and in the Results: Patients section, “intracranial therapy” has been amended to “CNS radiotherapy,” while the text “the type of intracranial radiotherapy was not always recorded by investigators, and only WBRT and SRS intracranial radiotherapy were reported” has been removed. All changes appear in the HTML and PDF versions of the article.
UR - https://www.scopus.com/pages/publications/85212171604
U2 - 10.1038/s41591-024-03349-0
DO - 10.1038/s41591-024-03349-0
M3 - Comment/Debate
C2 - 39653780
AN - SCOPUS:85212171604
SN - 1078-8956
VL - 30
SP - 3780
JO - Nature Medicine
JF - Nature Medicine
IS - 12
ER -
SDG 3 Good Health and Well-being